SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '4ymr'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Dali
Z-score		 Seq.
Identity (%)		 View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1NP1_A_HSMA303_1
(NITROPHORIN 1)		 4ymr PROTEIN SNX21
(Mus
musculus) 		4 / 5 GLU A 297
LEU A 303
LEU A 300
LEU A 302
 None
 0.87A 1np1A-4ymrA:
undetectable		 1np1A-4ymrA:
20.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2YLD_A_ASCA130_0
(CYTOCHROME C')		 4ymr PROTEIN SNX21
(Mus
musculus) 		4 / 5 ALA A 251
GLY A 278
CYH A 282
HIS A 283
 None
 1.38A 2yldA-4ymrA:
undetectable		 2yldA-4ymrA:
23.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2YLD_A_ASCA130_0
(CYTOCHROME C')		 4ymr PROTEIN SNX21
(Mus
musculus) 		4 / 5 ALA A 254
GLY A 278
CYH A 282
HIS A 283
 None
 1.48A 2yldA-4ymrA:
undetectable		 2yldA-4ymrA:
23.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2YLG_A_ASCA130_0
(CYTOCHROME C')		 4ymr PROTEIN SNX21
(Mus
musculus) 		4 / 5 ALA A 251
GLY A 278
CYH A 282
HIS A 283
 None
 1.41A 2ylgA-4ymrA:
undetectable		 2ylgA-4ymrA:
22.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2YLG_A_ASCA130_0
(CYTOCHROME C')		 4ymr PROTEIN SNX21
(Mus
musculus) 		4 / 5 ALA A 254
GLY A 278
CYH A 282
HIS A 283
 None
 1.44A 2ylgA-4ymrA:
undetectable		 2ylgA-4ymrA:
22.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LSF_E_PZIE800_0
(GLUTAMATE RECEPTOR 2)		 4ymr PROTEIN SNX21
(Mus
musculus) 		5 / 10 PRO A 310
SER A 267
GLY A 268
LEU A 362
ASP A 363
 None
 1.17A 3lsfB-4ymrA:
undetectable
3lsfE-4ymrA:
undetectable		 3lsfB-4ymrA:
22.92
3lsfE-4ymrA:
22.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ZWI_A_ASCA156_0
(CYTOCHROME C')		 4ymr PROTEIN SNX21
(Mus
musculus) 		4 / 5 ALA A 251
GLY A 278
CYH A 282
HIS A 283
 None
 1.38A 3zwiA-4ymrA:
undetectable		 3zwiA-4ymrA:
23.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ZWI_A_ASCA156_0
(CYTOCHROME C')		 4ymr PROTEIN SNX21
(Mus
musculus) 		4 / 5 ALA A 254
GLY A 278
CYH A 282
HIS A 283
 None
 1.49A 3zwiA-4ymrA:
undetectable		 3zwiA-4ymrA:
23.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CIP_A_ASCA130_0
(CYTOCHROME C')		 4ymr PROTEIN SNX21
(Mus
musculus) 		4 / 4 ALA A 251
GLY A 278
CYH A 282
HIS A 283
 None
 1.38A 4cipA-4ymrA:
1.8		 4cipA-4ymrA:
23.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CIP_A_ASCA130_0
(CYTOCHROME C')		 4ymr PROTEIN SNX21
(Mus
musculus) 		4 / 4 ALA A 254
GLY A 278
CYH A 282
HIS A 283
 None
 1.48A 4cipA-4ymrA:
1.8		 4cipA-4ymrA:
23.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5JLI_A_ASCA202_0
(CYTOCHROME C')		 4ymr PROTEIN SNX21
(Mus
musculus) 		4 / 5 ALA A 251
GLY A 278
CYH A 282
HIS A 283
 None
 1.38A 5jliA-4ymrA:
undetectable		 5jliA-4ymrA:
22.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5JLI_A_ASCA202_0
(CYTOCHROME C')		 4ymr PROTEIN SNX21
(Mus
musculus) 		4 / 5 ALA A 254
GLY A 278
CYH A 282
HIS A 283
 None
 1.45A 5jliA-4ymrA:
undetectable		 5jliA-4ymrA:
22.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5JSL_A_ASCA202_0
(CYTOCHROME C')		 4ymr PROTEIN SNX21
(Mus
musculus) 		4 / 4 ALA A 251
GLY A 278
CYH A 282
HIS A 283
 None
 1.38A 5jslA-4ymrA:
1.8		 5jslA-4ymrA:
23.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5JSL_A_ASCA202_0
(CYTOCHROME C')		 4ymr PROTEIN SNX21
(Mus
musculus) 		4 / 4 ALA A 254
GLY A 278
CYH A 282
HIS A 283
 None
 1.46A 5jslA-4ymrA:
1.8		 5jslA-4ymrA:
23.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5JT4_A_ASCA202_0
(CYTOCHROME C')		 4ymr PROTEIN SNX21
(Mus
musculus) 		4 / 5 ALA A 251
GLY A 278
CYH A 282
HIS A 283
 None
 1.41A 5jt4A-4ymrA:
undetectable		 5jt4A-4ymrA:
23.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5JT4_A_ASCA202_0
(CYTOCHROME C')		 4ymr PROTEIN SNX21
(Mus
musculus) 		4 / 5 ALA A 254
GLY A 278
CYH A 282
HIS A 283
 None
 1.45A 5jt4A-4ymrA:
undetectable		 5jt4A-4ymrA:
23.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6GNR_A_6J3A201_0
(TRANSTHYRETIN)		 4ymr PROTEIN SNX21
(Mus
musculus) 		4 / 4 LYS A 298
LEU A 276
ALA A 294
LEU A 279
 None
 1.48A 6gnrA-4ymrA:
undetectable		 6gnrA-4ymrA:
21.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6GNR_B_6J3B201_0
(TRANSTHYRETIN)		 4ymr PROTEIN SNX21
(Mus
musculus) 		4 / 4 LYS A 298
LEU A 276
ALA A 294
LEU A 279
 None
 1.47A 6gnrB-4ymrA:
undetectable		 6gnrB-4ymrA:
21.02